RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Shareholders

A collection of news and information related to Shareholders published by this site and its partners.

Top Shareholders Articles see all

Displaying items 1-5
  • Allergan adopts 'poison pill' defense in Valeant takeover bid

    Allergan adopts 'poison pill' defense in Valeant takeover bid
    Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
  • Allergan stock climbs amid $46-billion bid

     Allergan stock climbs amid $46-billion bid
    Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....

    Daniel Loeb keeps up pressure on Sotheby's

    Daniel Loeb keeps up pressure on Sotheby's
    Daniel Loeb, the lightening-rod hedge-fund manager, continued his assault on Sotheby's this week with a letter to the art auction house's shareholders asking them to vote for a new slate of board members that would include Loeb himself. In the letter,...

    Allergan says it 'will carefully review' Valeant offer

    Allergan says it 'will carefully review' Valeant offer
    Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer from the Canadian drug maker was...

    India's Sun Pharmaceutical to buy Ranbaxy Labs in $4-billion deal

    India's Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4-billion deal, the companies said Monday. The combined company will be India's biggest pharmaceutical firm, with annual revenue estimated at $4.2...